Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Different classes of neurons in the CNS utilize endogenous cannabinoids as retrograde messengers to shape afferent activity in a short- and long-lasting fashion. Transient suppression of excitation and inhibition as well as long-term depression or potentiation in many brain regions require endocannabinoids to be released by the postsynaptic neurons and activate presynaptic CB1 receptors. Memory consolidation and/or extinction and habit forming have been suggested as the potential behavioral consequences of endocannabinoid-mediated synaptic modulation. HOWEVER, ENDOCANNABINOIDS HAVE A DUAL ROLE: beyond a physiological modulation of synaptic functions, they have been demonstrated to participate in the mechanisms of neuronal protection under circumstances involving excessive excitatory drive, glutamate excitotoxicity, hypoxia-ischemia, which are key features of several neurodegenerative disorders. In this framework, the recent discovery that the endocannabinoid 2-arachidonoyl-glycerol is released by midbrain dopaminergic neurons, under both physiological synaptic activity to modulate afferent inputs and pathological conditions such as ischemia, is particularly interesting for the possible implication of these molecules in brain functions and dysfunctions. Since dopamine dysfunctions underlie diverse neuropsychiatric disorders including schizophrenia, psychoses, and drug addiction, the importance of better understanding the correlation between an unbalanced endocannabinoid signal and the dopamine system is even greater. Additionally, we will review the evidence of the involvement of the endocannabinoid system in the pathogenesis of Parkinson's disease, where neuroprotective actions of cannabinoid-acting compounds may prove beneficial.The modulation of the endocannabinoid system by pharmacological agents is a valuable target in protection of dopamine neurons against functional abnormalities as well as against their neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Getting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · cited 1×
“The observations that synthetic cannabinoids, as well as hempderived ones, and eCBs have powerful inhibitory effects on motor activity [37, 58, 169], together with the discovery that both eCBs and CB1 receptors are abundantly distributed in the basal ganglia [47, 84, 85], strongly suggest that this system is involved…”
Background2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 4×
“The CB1 receptor is the most abundant G protein-coupled receptor expressed in the brain [84, 90], but it is also found in diverse peripheral tissues (e.”
BackgroundInfluentialVanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142 · cited 1×
“Lastly, pharmacological studies revealed the existence of eCB targets other than CB receptors, including the transient receptor potential vanilloid-1 (TRPV1) receptor [223].”
BackgroundMolecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125 · cited 1×
“Then AEA and 2-AG are degraded by two well-characterized enzymes, the fatty acid amide hydrolase (FAAH) and the monoacylglycerol (MAG) lipase, respectively [36, 49, 196, 201].”
BackgroundThe Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · cited 1×
“Accordingly, dysfunctional eCB signal has been reported in PD and other movement disorders [16, 151, 170, 203].”
BackgroundThe molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · cited 6×
“The current model, proposing that activation of metabotropic receptors coupled to the PLC and diacylglycerol (DAG) lipase pathway leads to 2-AG production [156, 194], is substantiated by both the cloning of the enzyme 1,2-DAG lipase [11] and the contribution of ionotropic purinergic receptors (e.”
BackgroundInfluentialBehavioral Theories and the Neurophysiology of Reward
Schultz, W. (2006) · Annual Review of Psychology · doi:10.1146/annurev.psych.56.091103.070229 · Cited by 1,637 · cited 1×
“Switching from regular to burst firing is triggered by behavioural stimuli: reward prediction error [179-182] or the identification of contextual and behavioural stimuli responsible for unpredicted events [160].”
BackgroundIdentification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Neuronal Coding of Prediction Errors
Schultz, W., & Dickinson, A. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.473 · Cited by 1,427 · cited 1×
“Switching from regular to burst firing is triggered by behavioural stimuli: reward prediction error [179-182] or the identification of contextual and behavioural stimuli responsible for unpredicted events [160].”
BackgroundCaspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399 · cited 1×
“Additional evidence suggesting a link between cannabinoids and schizophrenia is that adolescent Cannabis consumption was associated with an higher incidence of schizophrenia in adulthood [4, 22, 220], when corrected for confounding variables.”
BackgroundBrain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 1×
“Then AEA and 2-AG are degraded by two well-characterized enzymes, the fatty acid amide hydrolase (FAAH) and the monoacylglycerol (MAG) lipase, respectively [36, 49, 196, 201].”
BackgroundCB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208 · cited 3×
“Because activation of the eCB system affects not only synaptic remodelling [42, 156], but also neuronal differentiation [172] and survival [128, 152], eCBs guarantee not only a fine regulation of information processing, but also local protective mechanisms directed at preserving brain physiological function [6, 27, 51…”
BackgroundDrugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons
Saal, D., Dong, Y., Bonci, A., & Malenka, R. C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00021-7 · Cited by 1,147
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039 · cited 1×
“The current model, proposing that activation of metabotropic receptors coupled to the PLC and diacylglycerol (DAG) lipase pathway leads to 2-AG production [156, 194], is substantiated by both the cloning of the enzyme 1,2-DAG lipase [11] and the contribution of ionotropic purinergic receptors (e.”
BackgroundMarsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937 · cited 1×
“However, several neuronal populations projecting to VTA or SNc DA neurons have been demonstrated to possess relatively large amounts of CB1 receptor mRNA, namely the glutamatergic neurons in the PFC and in the subthalamic nucleus, or the GABAergic neurons in the striatal complex as well as in the pars reticulata of th…”
BackgroundZammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871 · cited 1×
“Additional evidence suggesting a link between cannabinoids and schizophrenia is that adolescent Cannabis consumption was associated with an higher incidence of schizophrenia in adulthood [4, 22, 220], when corrected for confounding variables.”
BackgroundFunctional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
The short-latency dopamine signal: a role in discovering novel actions?
Redgrave, P., & Gurney, K. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2022 · Cited by 762 · cited 1×
“Switching from regular to burst firing is triggered by behavioural stimuli: reward prediction error [179-182] or the identification of contextual and behavioural stimuli responsible for unpredicted events [160].”
BackgroundDistribution of cannabinoid receptors in the central and peripheral nervous system
Mackie, K. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_10 · Cited by 744 · cited 1×
“monocytes, microglial cells, T- and B-cells), in the spleen and tonsils [59, 144, 156], and peripheral tissues [116].”
BackgroundDopamine operates as a subsecond modulator of food seeking
Roitman, M. F., Stuber, G. D., Phillips, P. E. M., Wightman, R. M., & Carelli, R. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3823-03.2004 · Cited by 718 · cited 1×
“This hypothesis is supported by the evidence that both pharmacological and genetic impairment of CB1 receptors inhibit motivated behaviours [33-35, 39-41, 52, 53, 108, 109, 123, 146, 176] as well as acquisition of natural rewards [166] and druginduced increased DA neurotransmission [26, 93, 155].”
BackgroundThe Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus
Monory, K., Massa, F., Egertová, M., Eder, M., Blaudzun, H., Westenbroek, R., Kelsch, W., Jacob, W., Marsch, R., Ekker, M., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.006 · Cited by 706
Gonon, F. G. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90307-7 · Cited by 676
Localization of cannabinoid receptor mRNA in rat brain
Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631 · cited 2×
“However, several neuronal populations projecting to VTA or SNc DA neurons have been demonstrated to possess relatively large amounts of CB1 receptor mRNA, namely the glutamatergic neurons in the PFC and in the subthalamic nucleus, or the GABAergic neurons in the striatal complex as well as in the pars reticulata of th…”
BackgroundCannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
Twitchell, W., Brown, S., & Mackie, K. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.1.43 · Cited by 544 · cited 1×
“However, additional studies found that the CB receptors are also coupled to ion channels through the Golf protein, resulting in the inhibition of Ca 2+ influx through N- [117], P/Q[200] and L- [65] type Ca 2+ channels, as well as the activation of inwardly rectifying potassium conductance and A currents [32, 118].”
BackgroundTeicher, M. H., Andersen, S. L., & Hostetter, J. C. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(95)00109-q · Cited by 505
It could be habit forming: drugs of abuse and striatal synaptic plasticity
Gerdeman, G. L., Partridge, J. G., Lupica, C. R., & Lovinger, D. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00065-1 · Cited by 480
Groenewegen, H. J., Berendse, H. W., & Haber, S. N. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90115-v · Cited by 456
Lastres-Becker, I., Molina-Holgado, F., Ramos, J. A., Mechoulam, R., & Fernández-Ruiz, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.11.009 · Cited by 407 · cited 1×
“Cannabinoids were also shown to be neuroprotective in animal models of PD, mainly for their known antioxidant and CB1 receptor-independent properties [63, 105], but an effect through activation of CB1 receptors cannot be excluded.”
BackgroundEndocannabinoid signaling system and brain reward: emphasis on dopamine
GARDNER, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.032 · Cited by 387 · cited 1×
“Many mechanisms of action have been proposed for the interactions between blockade of eCBs’ action and treatment of drug addiction [64, 107, 114, 124], and they all over-emphasize the interplay between the DA and eCB and/or opioid systems.”
BackgroundFunctional interaction between opioid and cannabinoid receptors in drug self-administration.
Navarro, M., Carrera, M. R. A., Fratta, W., Valverde, O., Cossu, G., Fattore, L., Chowen, J. A., Gómez, R., del Arco, I., Villanúa, M. A., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05344.2001 · Cited by 378 · cited 1×
“This hypothesis is supported by the evidence that both pharmacological and genetic impairment of CB1 receptors inhibit motivated behaviours [33-35, 39-41, 52, 53, 108, 109, 123, 146, 176] as well as acquisition of natural rewards [166] and druginduced increased DA neurotransmission [26, 93, 155].”
BackgroundPhasic Dopamine Release Evoked by Abused Substances Requires Cannabinoid Receptor Activation
Cheer, J. F., Wassum, K. M., Sombers, L. A., Heien, M. L. A. V., Ariansen, J. L., Aragona, B. J., Phillips, P. E. M., & Wightman, R. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4152-06.2007 · Cited by 374 · cited 1×
“This hypothesis is supported by the evidence that both pharmacological and genetic impairment of CB1 receptors inhibit motivated behaviours [33-35, 39-41, 52, 53, 108, 109, 123, 146, 176] as well as acquisition of natural rewards [166] and druginduced increased DA neurotransmission [26, 93, 155].”
BackgroundCannabinoids Enhance Subsecond Dopamine Release in the Nucleus Accumbens of Awake Rats
Cheer, J. F., Wassum, K. M., Heien, M. L. A. V., Phillips, P. E. M., & Wightman, R. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0529-04.2004 · Cited by 343
García-Arencibia, M., González, S., de Lago, E., Ramos, J. A., Mechoulam, R., & Fernández-Ruiz, J. (2007) · Brain Research · doi:10.1016/j.brainres.2006.11.063 · Cited by 320 · cited 1×
“Cannabinoids were also shown to be neuroprotective in animal models of PD, mainly for their known antioxidant and CB1 receptor-independent properties [63, 105], but an effect through activation of CB1 receptors cannot be excluded.”
BackgroundSynaptic regulation of mesocorticolimbic dopamine neurons
White, F. J. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.002201 · Cited by 289 · cited 1×
“GABAergic input is mostly from the striatal complex; it includes inputs from the NAc, the caudate nucleus, globus pallidus and ventral pallidum [77, 189, 190, 215].”
BackgroundCohen, C., Perrault, G., Griebel, G., & Soubrié, P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300541 · Cited by 251
Pistis, M., Perra, S., Pillolla, G., Melis, M., Muntoni, A. L., & Gessa, G. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.006 · Cited by 194
Self-citationAltering cannabinoid signaling during development disrupts neuronal activity
Bernard, C., Milh, M., Morozov, Y. M., Ben-Ari, Y., Freund, T. F., & Gozlan, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409641102 · Cited by 144
Cited by
Iannotti, F. A., Di Marzo, V., & Petrosino, S. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.02.002 · Cited by 357
Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
Peball, M., Krismer, F., Knaus, H., Djamshidian, A., Werkmann, M., Carbone, F., Ellmerer, P., Heim, B., Marini, K., Valent, D., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25864 · Cited by 123
Oxytocin functions as a spatiotemporal filter for excitatory synaptic inputs to VTA dopamine neurons
Xiao, L., Priest, M. F., & Kozorovitskiy, Y. (2018) · eLife · doi:10.7554/elife.33892 · Cited by 83
“Endocannabinoid signaling is suggested to be neuroprotective across multiple brain regions, including the hippocampus and midbrain dopamine regions (Melis and Pistis, 2007; Xu and Chen, 2015).”
BackgroundSancandi, M., Uysal-Onganer, P., Kraev, I., Mercer, A., & Lange, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082743 · Cited by 41
Metadata
- Authors
- Melis, M., & Pistis, M.
- Venue
- Current Neuropharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2007-12-01
- Volume
- 5
- Issue
- 4
- Pages
- 268-277
- ISSN
- 1570-159X (ISSN-L)
- OpenAlex
- W1978159453
- Cited by
- 53
- References
- 42
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.